|
|
|
|
|
|
|
Omeros Corp (OMER)
|
|
21.3 0.51 (2.45%)
|
05-22 09:59
|
|
Open:
|
21.04
|
Pre. Close:
|
20.79
|
|
High:
|
21.97
|
Low:
|
20.8
|
|
Volume:
|
250,793
|
Market Cap:
|
1029M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
21.09 - 21.192
|
21.192 - 21.28
|
|
Low:
|
19.822 - 19.937
|
19.937 - 20.036
|
|
Close:
|
20.614 - 20.796
|
20.796 - 20.954
|
|
|
|
Technical analysis (as of: 2018-05-21 4:32:11 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 29.43 One year: 34.38
|
|
Support:
|
Support1: 18.07 Support2: 13.66
|
|
Resistance:
|
Resistance1:
25.20 Resistance2: 29.43
|
|
Pivot:
|
18.32
|
|
Moving Averages:
|
MA(5): 21.12  MA(20): 17.34
MA(100): 14.83 MA(250): 17.87
|
|
MACD:
|
MACD(12,26):
1.92 Signal(12,26,9): 1.61
|
|
%K %D:
|
%K(14,3): 56.47 %D(3): 59.70
|
|
RSI:
|
RSI(14): 62.94
|
|
52-Week:
|
High: 27.09
Low: 8.36 Change(%): 31.2
|
|
Average Vol(K):
|
3-Month: 153347
10-Days 212160
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.OMER has closed below upper band by 28.9%. Bollinger Bands are 160.3% wider than normal. The large width of the bands suggest high volatility as compared to OMER's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-05-18T05:43:57-04:00
Omeros Corporation: What Do The Q1 2018 Earnings Foretell?
2018-05-16T13:00:10-04:00
Midday Gainers / Losers (05/16/2018)
2018-05-16T06:38:09-04:00
Rounds Report: Omeros Rallied Robustly While Stellar FDA Due Diligence To Help Orphan Disease Innovators
2018-05-16T03:55:30-04:00
Lucky Seven: Immune Design Takes Off, Institutions Place Bets On Viking Therapeutics
2018-05-14T10:00:00-04:00
Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President's Healthcare Plans
2018-05-14T08:19:53-04:00
Lucky Seven: Achaogen Likely To Bounce Back
2018-05-13T03:46:04-04:00
Rounds Report: Omeros Rallied While Stellar FDA Due Diligence To Help Atara Biotherapeutics
2018-05-12T00:23:51-04:00
Lucky Seven: Omeros Pops, Exelixis Drops On Phase 3 Flop
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
